What You Should Know:
- One Drop, an AI powered chronic condition management platform, and pharma giant Bayer - their strategic partner/investor released their co-developed digital, AI-enabled, cardiovascular disease (CVD) prevention module.
- The digital-first approach to CVD prevention provides a holistic set of digital tools and coaching placing One Drop members on a healthier path by personalizing care, gathering data, and
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know:
- Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences.
- Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic for Heart Failure
What You Should Know:
- Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).
- The Breakthrough Devices Program was created to provide patients and providers with timely access to medical devices (in this case, software as a medical device, or SaMD) by speeding up their
Read More
How NLP Can Uncover Social Determinants of Heart Disease
Heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. Cardiovascular disease-related deaths—which occur every 36 seconds—cost our country about $219 billion each year, according to the Centers for Disease Control and Prevention (CDC). People with poor cardiovascular health are also at increased risk of severe illness from COVID-19, so the time to act is now. There’s no time like the present to look at major risk factors—from obesity and
Read More
CorVista Health Nabs $65M for Non-Invasive Cardiac Diagnostic Platform
What You Should Know:
- CorVista Health, a Toronto-based digital health company dedicated to improving cardiovascular disease diagnosis, announced it has closed a $65 million Series C financing, bringing the total funding to nearly $100 million.
- This significant capital provides a runway for ongoing research, development and commercialization efforts for CorVista® System, the company’s non-invasive, point-of-care solution that allows physicians to rapidly test for heart disease.
- The
Read More
Casana Raises $14M to Expand IoT Heart Health Toilet Seat
What You Should Know:
- Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output.
Casana, previously known as Heart Health Intelligence, Inc., a healthcare technology firm that is re-inventing in-home health monitoring, today announced that it has raised $14M in Series A funding, bringing the total capital raised to
Read More
FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
What You Should Know:
- FCC announces initial 14 pilot project selected for $100M Connected Care Pilot Program that will support connected care service across the country and focus on low-income and veteran patients.
The Federal Communications
Commission (FCC) today announced an initial set of 14 pilot projects with
over 150 treatment sites in 11 states that have been selected for the Connected
Care Pilot Program. A total of $26.6 million will be awarded to these
applicants for
Read More
COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
What You Should Know:
- COVID-19 care deferrals lead to three major boomerang
conditions that payers and providers must proactively address in 2021,
according to a newly released report by Prealize.
- COVID-19’s hidden victims—those who avoided or deferred
care during the pandemic—will increasingly return to the healthcare system, and
many will be diagnosed with new conditions at more advanced stages. Healthcare
leaders must act now to keep this boomerang from driving worse outcomes
Read More
Highmark Taps Lark Health for AI-Driven Chronic Disease Management/Prevention
What
You Should Know:
-
Highmark, one of the largest Blues plans, has chosen Lark Health for its
chronic disease prevention and management platform.
-
Members will have access to Lark’s 24/7 AI-based coaching and programs to
manage diabetes, hypertension, and prevent chronic conditions.
Highmark Inc., America's fourth-largest overall Blue Cross Blue Shield-affiliated organization, announced a growing collaboration with Lark Health, virtual chronic disease prevention and management
Read More
How Care Coordination Technology Addresses Social Isolation in Seniors
Senior isolation is a health risk that affects at least a quarter of seniors over 65. It has become recognized over the past decade as a risk factor for poor aging outcomes including cognitive decline, depression, anxiety, Alzheimer’s disease, obesity, hypertension, heart disease, impaired immune function, and even death.
Physical limitations, lack of transportation, and inadequate health literacy, among other social determinants of health (SDOH), further impair access to medical and mental
Read More
